and/or apremilast. This conditional recommendation now includes apremilast, but it is otherwise unchanged from the 2017 guideline. Four observational studies provided additional indirect evidence to the previous systematic literature review and found no relationship between the included drugs and the risk of postoperative infections, although the number of included cases and events were low For patients with RA, AS, PsA, or JIA undergoing elective THA or TKA, withholding all biologics,